Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. ResMed (RMD) is back in focus after reporting higher sales and net income for ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre ...

Sydney: Sleep-breathing device maker ResMed plans to take global a doctor ‍education program aimed at promoting the screening of patients seeking Ozempic-style weight loss drugs for apnea, ⁠calling ...

SYDNEY, Feb 3 (Reuters) - Sleep-breathing device maker ResMed (RMD.N), opens new tab plans to take global a doctor education program aimed at promoting the screening of patients seeking Ozempic-style ...

Now could be the time to buy ResMed Inc (ASX: RMD) shares. That's the view of analysts at Morgans, who have turned positive on the sleep disorder-focused medical device company following its ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

RMD is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of RMD shares has increased $1.13 since the market last closed. This is a 0.44% ...

That’s been the question floating around ResMed’s (ASX:RMD) HQ for the past five years, given its obstructive sleep apnea (OSA) therapy rival’s absence from the US device market owing to a product ...

What’s going on here? ResMed's second-quarter earnings soared on the back of increased demand for sleep apnea devices, such as CPAP machines, surpassing Wall Street's expectations. ResMed posted a 10% ...

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, ...